Increased synthesis of ErbB members including epidermal growth factor receptor EGFR, ErbB2, ErbB3, and ErbB4, which are associated with the development of solid tumours, such as tumours associated with breast, colorectal and ovarian cancer (43). Here, EGFR is linked to ovarian cancer.